Angina Peripheral Arterial Disease Pharmacology 
Frontiers in Cardiovascular Medicine
FEBRUARY 27, 2024
Patients with a new or recurrent episode of ASCVD (angina, acute myocardial infarction, transient ischemic attack, stroke, or peripheral arterial disease) between 1-Jan-2017 and 31-Dec-2018 were included.
DAIC
JANUARY 23, 2024
21-23 hsCRP is nonspecific inflammatory marker and an acute phase reactant that predicts the likelihood of a heart attack, stroke, peripheral artery disease and sudden cardiac death among healthy individuals with no history of CV disease, and recurrent events and death in patients with known ASCVD.22 2015;45(3):341-350.
Expert insights. Personalized for you.
45 
Let's personalize your content